Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

obs and gynae > Cancer > Flashcards

Cancer Flashcards

(74 cards)

Start Studying
1
Q

Ctype of epithelium in cervical cancer

A

s.c.c (most common)
adeno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

associations of cervical cancer

A

Human papilloma virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when vaccinated against HPV

A

12-13 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

if HPV +ve increased risk of what other cancers

A

anal
vulval
vaginal
penis
mouth and throat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 important strains of HPV

A

type 16 and 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what tell pt with HPV +VE

A

no treatment for infection with HPV. Most cases resolve spontaneously within two years, while some will persist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pathophysiology of HPV causing cervical cancer

A

P53 and pRb are tumour suppressor genes. They have a role in suppressing cancers from developing. HPV produces two proteins (E6 and E7) that inhibit these tumour suppressor genes. The E6 protein inhibits p53, and the E7 protein inhibits pRb. Therefore, HPV promotes the development of cancer by inhibiting tumour suppressor genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risk fx of cervical cancer

A

Increased risk of catching HPV
Later detection of precancerous and cancerous changes (non-engagement with screening)
Other risk factors
Smoking
HIV (patients with HIV are offered yearly smear tests)
Combined contraceptive pill use for more than five years
Increased number of full-term pregnancies
Family history
Exposure to diethylstilbestrol during fetal development (this was previously used to prevent miscarriages before 1971)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

increased risk of catching HPV

A

Early sexual activity
Increased number of sexual partners
Sexual partners who have had more partners
Not using condoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

presentation of cervical cancer

A

asx - screening
Abnormal vaginal bleeding (intermenstrual, postcoital or post-menopausal bleeding)
Vaginal discharge
Pelvic pain
Dyspareunia (pain or discomfort with sex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ix for cervical cancer

A

examine cervix with speculum and swab
if abnormal - urgent referral for colposcopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cervical appearance requiring 2WW

A

Ulceration
Inflammation
Bleeding
Visible tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

grading system for dysplasia in cervical cancer

A

CIN
CIN I: mild dysplasia, affecting 1/3 the thickness of the epithelial layer, likely to return to normal without treatment
CIN II: moderate dysplasia, affecting 2/3 the thickness of the epithelial layer, likely to progress to cancer if untreated
CIN III: severe dysplasia, very likely to progress to cancer if untreated/carcinoma in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how screening for cervical cancer

A

The cells are deposited from the brush into a preservation fluid. This fluid is transported to a lab where the cells are examined under a microscope for precancerous changes (dyskaryosis). This way of transporting the cells is called liquid-based cytology.
tested for high risk HPV, if -ve, cells not examined and smear is negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when attend cervical screening

A

Every three years aged 25 – 49
Every five years aged 50 – 64

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

cervical screening additional testing circumstances

A

Women with HIV are screened annually
Women over 65 may request a smear if they have not had one since aged 50
Women with previous CIN may require additional tests (e.g. test of cure after treatment)
Certain groups of immunocompromised women may have additional screening (e.g. women on dialysis, cytotoxic drugs or undergoing an organ transplant)
Pregnant women due a routine smear should wait until 12 weeks post-partum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

infections found on smear

A

BV
candidiasis
trichomoniasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IUS infection associated

A

Actinomyces-like organisms are often discovered in women with an intrauterine device (coil). These do not require treatment unless they are symptomatic. Where the woman is symptomatic (e.g. pelvic pain or abnormal bleeding), removal of the intrauterine device

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Summary of mx from smear results

A

Inadequate sample – repeat the smear after at least three months
HPV negative – continue routine screening
HPV positive with normal cytology – repeat the HPV test after 12 months
HPV positive with abnormal cytology – refer for colposcopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is colposcopy

A

inserting a speculum and using equipment (a colposcope) to magnify the cervix. This allows the epithelial lining of the cervix to be examined in detail. During colposcopy, stains such as acetic acid and iodine solution can be used to differentiate abnormal areas
If abnormal - white with acetate, not stain wirh iodine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How get tissue sample during colposcopy

A

Punch biopsy
Large loop excision of transformation zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Large loop excision of the transformation zone how work

A

Local anaesthetic
using a loop of wire with electrical current (diathermy) to remove abnormal epithelial tissue on the cervix. The electrical current cauterises the tissue and stops bleeding.
S/e - bleeding and abnormal discharge, increases risk of pre term labour
C/i - using tampons or sex after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cone biopsy how work

A

Indications - can be used for tx for CIN and very early stage cancer
General anaesthetic
Sent for histology
Risks -Pain
Bleeding
Infection
Scar formation with stenosis of the cervix
Increased risk of miscarriage and premature labour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Staging cervical cancer

A

FIGO
Stage 1: Confined to the cervix
Stage 2: Invades the uterus or upper 2/3 of the vagina
Stage 3: Invades the pelvic wall or lower 1/3 of the vagina
Stage 4: Invades the bladder, rectum or beyond the pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Mx of cervical cancer
Cervical intraepithelial neoplasia and early-stage 1A: LLETZ or cone biopsy Stage 1B – 2A: Radical hysterectomy and removal of local lymph nodes with chemotherapy and radiotherapy Stage 2B – 4A: Chemotherapy and radiotherapy Stage 4B: Management may involve a combination of surgery, radiotherapy, chemotherapy and palliative care
26
Survival cervical cancer
The 5-year survival drops significantly with more advanced cervical cancer, from around 98% with stage 1A to around 15% with stage 4.
27
Mx of advanced cervical cancer
Pelvic exenteration - removing most or all of the pelvic organs, including the vagina, cervix, uterus, fallopian tubes, ovaries, bladder and rectum.
28
Chemo Tx of cervical cancer
Bevacizumab (avastin) - targets vascular endothelial growth factor A (VEGF-A), which is responsible for the development of new blood vessels. Therefore, it reduces the development of new blood vessels. You may also come across this medication as a treatment for wet age-related macular degeneration
29
HPV strains causing genital warts
6 and 11
30
When HPV vaccine given?
Before sexually active
31
Type of epithelium endometrial cancer
Adenocarcinoma
32
Typical presentation of endometrial cancer
any woman presenting with postmenopausal bleeding has endometrial cancer until proven otherwise
33
Key risk fx for endometrial cancer
Obesity DM
34
Endometrial hyperplasia types
Hyperplasia without atypia Atypical hyperplasia
35
How endometrial hyperplasia tx
Intrauterine system (e.g. Mirena coil) Continuous oral progestogens (e.g. medroxyprogesterone or levonorgestrel)
36
Risk fx endometrial cancer
Unopposed oestrogen stimulates the endometrial cells and increases the risk of endometrial hyperplasia and cancer
37
Risk fx of unopposed oestrogen
Increased age Earlier onset of menstruation Late menopause Oestrogen only hormone replacement therapy No or fewer pregnancies Obesity Polycystic ovarian syndrome Tamoxifen
37
PCOS unopposed oestrogen
Usually, when ovulation occurs, a corpus luteum is formed in the ovaries from the ruptured follicle that released the egg. It is this corpus luteum that produces progesterone, providing endometrial protection during the luteal phase of the menstrual cycle (the second half of the menstrual cycle). Women with polycystic ovarian syndrome are less likely to ovulate and form a corpus luteum.
38
Main cause of unopposed oestrogen in postmenopausal women
Obesity - Adipose tissue contains aromatase, which is an enzyme that converts androgens such as testosterone into oestrogen. Androgens are produced mainly by the adrenal glands. In women with more adipose tissue, and therefore more aromatase enzyme, more of these androgens are converted to oestrogen Also not ovulating so no corpus luteum to produce progesterone
39
Drug that increases risk of endometrial cancer
Tamoxifen
40
Risk fx of endometrial cancer unrelated to unopposed oestrogen
Type 2 diabetes Hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome
41
Protective fx against endometrial cancer
Combined contraceptive pill Mirena coil Increased pregnancies Cigarette smoking
42
Presentation of endometrial cancer
Post menopausal bleeding! Postcoital bleeding Intermenstrual bleeding Unusually heavy menstrual bleeding Abnormal vaginal discharge Haematuria Anaemia Raised platelet count
43
Referral for endometrial cancer
a 2-week-wait urgent cancer referral for endometrial cancer is: Postmenopausal bleeding (more than 12 months after the last menstrual period) NICE also recommends referral for a transvaginal ultrasound in women over 55 years with: Unexplained vaginal discharge Visible haematuria plus raised platelets, anaemia or elevated glucose levels
44
Ix for endometrial cancer
Transvaginal ultrasound for endometrial thickness (normal is less than 4mm post-menopause) Pipelle biopsy, which is highly sensitive for endometrial cancer making it useful for excluding cancer Hysteroscopy with endometrial biopsy
45
Stages of endometrial cancer
FIGO Stage 1: Confined to the uterus Stage 2: Invades the cervix Stage 3: Invades the ovaries, fallopian tubes, vagina or lymph nodes Stage 4: Invades bladder, rectum or beyond the pelvis
46
Mx of endometrial cancer
stage 1 and 2 endometrial cancer is a total abdominal hysterectomy with bilateral salpingo-oophorectomy, also known as a TAH and BSO (removal of uterus, cervix and adnexa radical hysterectomy involves also removing the pelvic lymph nodes, surrounding tissues and top of the vagina Radiotherapy Chemotherapy Progesterone may be used as a hormonal treatment to slow the progression of the cancer
47
Types of ovarian cancer
Epithelial cell tumours Dermoid cysts Sex cord stromal tumours Mets
48
Types of epithelial cell tumours
Serous tumours (the most common) Endometrioid carcinomas Clear cell tumours Mucinous tumours Undifferentiated tumours
49
Dermoid cysts clinical do
tissue types, such as skin, teeth, hair and bone.
50
Associations of Dermoid cysts
Ovarian torsion
51
Germ cell tumours markers
alpha-fetoprotein (α-FP) and human chorionic gonadotrophin (hCG)
52
Types of sex cord stromal tumours
Sertoli–Leydig cell tumours and granulosa cell tumours.
53
Term for metastatic ovarian cancer
Krukenberg tumour refers to a metastasis in the ovary, usually from a gastrointestinal tract cancer, particularly the stomach
54
Krukenberg tumours on histology
Signet ring cells
55
Risk fx for ovarian cancer
Age (peaks age 60) BRCA1 and BRCA2 genes (consider the family history) Increased number of ovulations Obesity Smoking Recurrent use of clomifene
56
Protective fx of ovarian cancer
Combined contraceptive pill Breastfeeding Pregnancy
57
Ovarian cancer clinical fx
Abdominal bloating Early satiety (feeling full after eating) Loss of appetite Pelvic pain Urinary symptoms (frequency / urgency) Weight loss Abdominal or pelvic mass Ascites may press on the obturator nerve and cause referred hip or groin pain.
58
Referral criteria ovarian cancer
2-week-wait referral if a physical examination reveals: Ascites Pelvic mass (unless clearly due to fibroids) Abdominal mass
59
Ix for ovarian cancer
Ca125 (>35 IU/mL is significant) Pelvic ultrasound Further: CT Histology Paracentesis
60
Risk scoring of ovarian mass being malignant
Risk of malignancy index Menopausal status Ultrasound findings CA125 level
61
When germ cell tumours more likely
<40 with complex ovarian mass
62
Other causes of raised ca 125
Non specific - Endometriosis Fibroids Adenomyosis Pelvic infection Liver disease Pregnancy
63
Staging of ovarian cancer
FIGO Stage 1: Confined to the ovary Stage 2: Spread past the ovary but inside the pelvis Stage 3: Spread past the pelvis but inside the abdomen Stage 4: Spread outside the abdomen (distant metastasis)
64
Mx of ovarian cancer
gynaecology oncology MDT. It usually involves a combination of surgery and chemotherapy.
65
Types of epithelium vulval cancer
S.c.c Malignant melanoma
66
Risk fx for vulval cancer
Advanced age (particularly over 75 years) Immunosuppression Human papillomavirus (HPV) infection Lichen sclerosus
67
Premalignant vulval cancer
VIN : High grade squamous intraepithelial lesion is a type of VIN associated with HPV infection that typically occurs in younger women aged 35 – 50 years. Differentiated VIN is an alternative type of VIN associated with lichen sclerosus and typically occurs in older women (aged 50 – 60 years).
68
Diagnosis of VIN
Biopsy
69
Tx of VIN
Watch and wait with close followup Wide local excision (surgery) to remove the lesion Imiquimod cream Laser ablation
70
VIN clinical fx
Vulval lump Ulceration Bleeding Pain Itching Lymphadenopathy in the groin
71
O/E vulval cancer
Labia majors - Irregular mass Fungating lesion Ulceration Bleeding
72
Mxof vulval cancer
Wide local excision to remove the cancer Groin lymph node dissection Chemotherapy Radiotherapy
73

obs and gynae (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions